Genitourinary Cancer News

An analysis of online conversations among health care professionals on social media in December revealed collective enthusiasm following approval of the first two gene therapies for treatment of sickle cell disease.

The percentage of patients with advanced cancers who died within a month of beginning immunotherapy rose significantly in the last decade, study results published in JAMA Oncology showed.

MADRID — Remarkable. Highly meaningful. Monumental.

The FDA approved enfortumab vedotin-ejfv in combination with pembrolizumab for patients with locally advanced or metastatic urothelial cancer, according to an agency press release.

The FDA approved belzutifan for treatment of adults with advanced renal cell carcinoma.

NASHVILLE, Tenn. — Insurance status appeared associated with survival among patients with metastatic renal cell carcinoma, according to findings presented at International Kidney Cancer Symposium: North America.

NASHVILLE, Tenn. — A fully automated artificial intelligence approach predicted post-nephrectomy glomerular filtration rate with comparable accuracy as validated clinical prediction models, according to study results.

For individuals diagnosed with cancer, guideline-concordant exercise reduced all-cause mortality by 25% compared with patients with cancer who did not exercise, study results published in Journal of Clinical Oncology showed.

Higher BMI increased the risk for obesity-related cancer among a cohort of European adults, irrespective of cardiometabolic disease status, according to study results.

MADRID — MEDI5752, a novel bispecific antibody binding to CTLA-4 and PD-1, showed potential as a first-line treatment in patients with advanced clear cell renal cell carcinoma, according to data presented at ESMO Congress.